Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 29a-5p (miR-29a-5p) messenger RNA targets refer to the collective group of endogenous genes whose expression is post-transcriptionally regulated by the 5p strand of the miR-29a precursor. As a member of the miR-29 family, miR-29a-5p functions by binding to the 3' untranslated regions (UTRs) of specific mRNAs, facilitating their degradation or inhibiting their translation through the RNA-induced silencing complex (miRBase, 2023). Key validated targets of this microRNA family include DNA methyltransferases such as DNMT3A and DNMT3B, as well as anti-apoptotic factors like MCL1, which are critical in the progression of various cancers and epigenetic remodeling (PubMed: 17360452). Furthermore, miR-29a-5p is heavily involved in regulating extracellular matrix components and collagen production, making its target network a significant focus in the study of fibrotic and cardiovascular diseases (PubMed: 21103332). Therapeutic strategies often involve using miRNA mimics to suppress these targets or antagomirs to upregulate them; however, the broad regulatory reach of a single miRNA poses substantial challenges for drug specificity and safety. Consequently, monitoring the expression of these diverse mRNA targets is essential for evaluating the efficacy and potential off-target toxicity of miRNA-based therapeutics (PubMed: 24403312).
MicroRNA-29a-5p regulates gene expression by binding to complementary sequences in the 3' untranslated region (UTR) of target mRNAs, leading to translational repression or mRNA degradation via the RNA-induced silencing complex (RISC) (PubMed: 24403312).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 29a-5p messenger RNA targets (miR-29a-5p targets).